Carnegie Investment Counsel’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-108,070
Closed -$2.83M 513
2021
Q3
$2.83M Buy
108,070
+11,395
+12% +$276K 0.11% 163
2021
Q2
$2.34M Buy
96,675
+32,480
+51% +$799K 0.09% 176
2021
Q1
$1.6M Buy
+64,195
New +$1.7M 0.07% 201

Other funds holding SHC

Carnegie Investment Counsel's SHC Position: Q4 2021 in Review

Carnegie Investment Counsel sold out of Sotera Health (SHC) in Q4 2021, closing a stake of 108,070 shares — an estimated $2.83M sold.

Carnegie Investment Counsel first reported a position in SHC in Q1 2021 and held it in 3 quarters. The position peaked at $2.83M in Q3 2021. 146 funds tracked by Wall St. Rank hold SHC as of Q4 2021.

  • Carnegie Investment Counsel reported no remaining Sotera Health position as of Q4 2021 after selling out during the quarter.
  • Carnegie Investment Counsel sold 108,070 Sotera Health shares in Q4 2021, an estimated $2.83M.
  • Carnegie Investment Counsel first reported a position in Sotera Health in Q1 2021 and held it in 3 quarters.
  • Carnegie Investment Counsel's Sotera Health position peaked at $2.83M in Q3 2021.
  • 146 funds tracked by Wall St. Rank held Sotera Health as of Q4 2021.

Based on Carnegie Investment Counsel's 13F filing for Q4 2021, filed 21 Jan 2022.